SCHEMBL10073830

SCHEMBL10073830

CCOC(=O)/C=C/C1CCC(C2CCC(/C=C/C(=O)OCC)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 3/20 0.40
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 3/20 0.36
TTR P02766 1/20 0.35
DPP4 P27487 1/20 0.35
ATM Q13315 1/20 0.34
ESR2 Q92731 1/20 0.34
LMNA P02545 1/20 0.33
MDM2 Q00987 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7512241 0.94 HCAR2 (0.52) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL18828565 0.94 HCAR2 (0.52) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL7512242 0.94 HCAR2 (0.52) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL9465267 0.93 HCAR2 (0.42) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL14864454 0.92 HCAR2 (0.41) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL6516202 0.89 HCAR2 (0.39) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL3476790 0.89 HCAR2 (0.39) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL6516200 0.89 HCAR2 (0.39) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL6516208 0.89 HCAR2 (0.39) HCAR2L3MBTL1MAPTTDP1CA12
SCHEMBL3476789 0.89 HCAR2 (0.39) HCAR2L3MBTL1MAPTTDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372307-B2 Cyclohexylene reactive mesogens and their applications MERCK PATENT GMBH (DE) 2013-02-12 US disclosed
US-8372307-B2 Cyclohexylene reactive mesogens and their applications MERCK PATENT GMBH (DE) 2013-02-12 US disclosed
EP-2087067-B1 CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS MERCK PATENT GMBH (DE) 2012-06-27 EP disclosed
US-20100103366-A1 Cyclohexylene Reactive Mesogens and Their Applications MERCK PATENT GMBH (DE) 2010-04-29 US disclosed
US-20100103366-A1 Cyclohexylene Reactive Mesogens and Their Applications MERCK PATENT GMBH (DE) 2010-04-29 US disclosed
WO-2008061606-A1 CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS MERCK PATENT GMBH (DE) 2008-05-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100103366-A1 Cyclohexylene Reactive Mesogens and Their Applications CUTA, MC1R, CTSG HCAR2 860/4885L3MBTL1 2830/4885MAPT 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.